SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-004757
Filing Date
2018-03-07
Accepted
2018-03-07 17:11:41
Documents
76
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vktx-10k_20171231.htm 10-K 3328873
2 EX-23.1 vktx-ex231_6.htm EX-23.1 2682
3 EX-31.1 vktx-ex311_9.htm EX-31.1 20612
4 EX-31.2 vktx-ex312_7.htm EX-31.2 20606
5 EX-32.1 vktx-ex321_8.htm EX-32.1 12675
6 GRAPHIC g2018030720245644742528.jpg GRAPHIC 15117
  Complete submission text file 0001564590-18-004757.txt   11205304

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vktx-20171231.xml EX-101.INS 2304579
8 XBRL TAXONOMY EXTENSION SCHEMA vktx-20171231.xsd EX-101.SCH 73933
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20171231_cal.xml EX-101.CAL 55217
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20171231_def.xml EX-101.DEF 311465
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20171231_lab.xml EX-101.LAB 526304
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20171231_pre.xml EX-101.PRE 476744
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37355 | Film No.: 18674118
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences